Capital World Investors’s Xenon Pharmaceuticals XENE Stock Holding History

Capital World Investors’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.1M	Buy	862,775 +22,703	+3%	+$1.26M	0.01%	481
2026 Q1	$48.9M	Buy	840,072 +184,335	+28%	+$8.49M	0.01%	460
2025 Q4	$29.4M	Hold	655,737	–	–	﹤0.01%	460
2025 Q3	$26.3M	Hold	655,737	–	–	﹤0.01%	467
2025 Q2	$20.5M	Sell	655,737 -1,568,978	-71%	-$51.2M	﹤0.01%	472
2025 Q1	$74.6M	Sell	2,224,715 -69,822	-3%	-$2.65M	0.01%	361
2024 Q4	$89.9M	Sell	2,294,537 -387,000	-14%	-$16M	0.01%	352
2024 Q3	$106M	Hold	2,681,537	–	–	0.02%	335
2024 Q2	$105M	Hold	2,681,537	–	–	0.02%	328
2024 Q1	$115M	Hold	2,681,537	–	–	0.02%	332
2023 Q4	$124M	Buy	2,681,537 +406,563	+18%	+$14.4M	0.02%	321
2023 Q3	$77.7M	Hold	2,274,974	–	–	0.02%	353
2023 Q2	$87.6M	Hold	2,274,974	–	–	0.02%	353
2023 Q1	$81.4M	Hold	2,274,974	–	–	0.02%	346
2022 Q4	$89.7M	Hold	2,274,974	–	–	0.02%	344
2022 Q3	$82.1M	Hold	2,274,974	–	–	0.02%	352
2022 Q2	$69.2M	Hold	2,274,974	–	–	0.01%	364
2022 Q1	$69.5M	Hold	2,274,974	–	–	0.01%	389
2021 Q4	$71.1M	Buy	2,274,974 +1,311,474	+136%	+$39.2M	0.01%	400
2021 Q3	$14.7M	Hold	963,500	–	–	﹤0.01%	545
2021 Q2	$17.9M	Hold	963,500	–	–	﹤0.01%	537
2021 Q1	$17.2M	Hold	963,500	–	–	﹤0.01%	525
2020 Q4	$14.8M	Hold	963,500	–	–	﹤0.01%	505
2020 Q3	$10.7M	Hold	963,500	–	–	﹤0.01%	506
2020 Q2	$12.1M	Hold	963,500	–	–	﹤0.01%	465
2020 Q1	$10.9M	Hold	963,500	–	–	﹤0.01%	440
2019 Q4	$12.6M	Hold	963,500	–	–	﹤0.01%	455
2019 Q3	$8.68M	Hold	963,500	–	–	﹤0.01%	476
2019 Q2	$9.5M	Hold	963,500	–	–	﹤0.01%	490
2019 Q1	$9.79M	Hold	963,500	–	–	﹤0.01%	484
2018 Q4	$6.08M	Hold	963,500	–	–	﹤0.01%	492
2018 Q3	$12.7M	Sell	963,500 -465,500	-33%	-$5.39M	﹤0.01%	497
2018 Q2	$13.1M	Hold	1,429,000	–	–	﹤0.01%	487
2018 Q1	$7M	Hold	1,429,000	–	–	﹤0.01%	487
2017 Q4	$4.04M	Hold	1,429,000	–	–	﹤0.01%	489
2017 Q3	$4.22M	Hold	1,429,000	–	–	﹤0.01%	485
2017 Q2	$4.5M	Hold	1,429,000	–	–	﹤0.01%	483
2017 Q1	$5.72M	Buy	1,429,000 +204,000	+17%	+$1.6M	﹤0.01%	476
2016 Q4	$9.43M	Buy	1,225,000 +195,000	+19%	+$1.57M	﹤0.01%	454
2016 Q3	$8.34M	Hold	1,030,000	–	–	﹤0.01%	461
2016 Q2	$6.1M	Hold	1,030,000	–	–	﹤0.01%	469
2016 Q1	$7.2M	Hold	1,030,000	–	–	﹤0.01%	459
2015 Q4	$8.28M	Hold	1,030,000	–	–	﹤0.01%	487
2015 Q3	$8.51M	Buy	1,030,000 +370,503	+56%	+$3.68M	﹤0.01%	483
2015 Q2	$7.6M	Hold	659,497	–	–	﹤0.01%	503
2015 Q1	$11.1M	Hold	659,497	–	–	﹤0.01%	481
2014 Q4	$11.7M	Buy	+659,497	New	+$9.68M	﹤0.01%	479

Other funds holding XENE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Capital World Investors's XENE Position: Q2 2026 in Review

Capital World Investors increased its Xenon Pharmaceuticals (XENE) stake by 2.7% in Q2 2026, buying an estimated $1.26M and bringing the position to 862,775 shares worth $52.1M. The position accounts for 0.01% of the portfolio, ranked #481.

Capital World Investors first reported a position in XENE in Q4 2014 and has held it in 47 quarters since. The position peaked at $124M in Q4 2023. 193 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Capital World Investors held 862,775 shares of Xenon Pharmaceuticals worth $52.1M as of Q2 2026.
Capital World Investors bought 22,703 Xenon Pharmaceuticals shares in Q2 2026, an estimated $1.26M.
Xenon Pharmaceuticals made up 0.01% of Capital World Investors's portfolio in Q2 2026, its #481 holding.
Capital World Investors first reported a position in Xenon Pharmaceuticals in Q4 2014 and has held it in 47 quarters since.
Capital World Investors's Xenon Pharmaceuticals position peaked at $124M in Q4 2023.
193 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.